In vitro and in vivo study of water-soluble prodrugs of dexanabinol
- 1 November 1999
- journal article
- Published by American Geophysical Union (AGU) in Journal of Pharmaceutical Sciences
- Vol. 88 (11) , 1156-1160
- https://doi.org/10.1021/js990098j
Abstract
Trialkylammonium acetoxymethyl esters of dexanabinol were synthesized and evaluated as water-soluble prodrugs. Syntheses were performed by conventional methods; solubility in water and stability in buffers and human plasma were determined by HPLC, and in vivo tissue distribution studies were performed in a rat model. Most of the new derivatives were soluble in water (approximately 50 mg/mL). They were relatively stable in water, while rapidly hydrolyzed in human plasma. Distribution studies indicated that peak concentrations of drug both in blood (30 microg/mL) and brain (2 microg/mL) were rapidly (5 min) achieved after iv administration of a selected prodrug to rats. The blood concentration decreased faster than brain levels which were detectable even after 24 h. Some of the examined esters could be further developed as water soluble prodrugs of dexanabinol.Keywords
This publication has 10 references indexed in Scilit:
- Synthesis of deuterated dexanabinol, a nonpsychotropic cannabinoid with neuroprotective propertiesJournal of Labelled Compounds and Radiopharmaceuticals, 1998
- ALLYLIC AND PHENOLIC PHOSPHATE ESTERS OF DEXANABINOLOrganic Preparations and Procedures International, 1997
- Dimerization of dexanabinol by hydrogen bonding accounts for its hydrophobic characterInternational Journal of Quantum Chemistry, 1997
- Derivatives of Dexanabinol. I. Water-Soluble Salts of Glycinate EstersPharmaceutical Research, 1996
- Derivatives of Dexanabinol. II. Salts of Amino Acid Esters Containing Tertiary and Quaternary Heterocyclic Nitrogen with Increased Water-SolubilityPharmaceutical Research, 1996
- Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonistEuropean Journal of Pharmacology, 1995
- Gas Chromatography/Tandem Mass Spectrometry Measurement of Δ9-Tetrahydrocannabinol, Naltrexone, and Their Active Metabolites in PlasmaTherapeutic Drug Monitoring, 1993
- A Nonpsychotropic Cannabinoid, HU-211, Has Cerebroprotective Effects After Closed Head Injury in the RatJournal of Neurotrauma, 1993
- Synthesis of the individual, pharmacologically distinct, enantiomers of a tetrahydrocannabinol derivativeTetrahedron: Asymmetry, 1990
- Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker.Proceedings of the National Academy of Sciences, 1989